BiotechTube
Home/Agathos Biologics/John Ballantyne
JB

John Ballantyne

Co-Founder

Agathos Biologics

Therapeutic Areas

Gene TherapyImmunology

Agathos Biologics Pipeline

DrugIndicationPhase
AE1-BHK Cell LineBiomanufacturing PlatformDevelopment
AAV Reference StandardAnalytics/QC ToolDevelopment
Therapeutic ProgramsUndisclosedPre-clinical

Leadership Team at Agathos Biologics

JW
James W. Brown, Ph.D.
CEO & Co-Founder
MC
Michael Chambers
Co-Founder
DV
Douglas VanderMeulen
Senior Ethical Advisor
View full Agathos Biologics profile